Glenmark Pharmaceuticals enters exclusive agreement with Cyndea Pharma S.L.

Equity tips:-
                                               

  • A  global  pharmaceutical  company,  announced  today  it  has entered  into  a  development,  license, manufacture  and  commercial  supply  agreement with Cyndea Pharma S.L., granting exclusive rights to use their technology for developing  generic, soft‐gelatin capsule formulations of certain pharmaceutical products.
  • "As many as 70 percent of small molecule pharmaceuticals are difficult for the body to absorb,  which leads to challenges in developing effective oral formulations for these medicines,” said  Robert Matsuk, President, North America, Global API at Glenmark Pharmaceuticals. “Because of  these challenges, the use of soft-gelatin capsules have wide applications to improve absorption  and bioavailability of these medicines. Accessing this formulation and manufacturing technology  with our strategic partner Cyndea will support Glenmark’s continued mission of providing  important and cost‐effective generic medicines to patients."
  • Under this agreement, Glenmark receives exclusive rights to the United States and Canada  markets for these soft‐gelatin formulations in exchange for sharing development costs and  profits from future sales. In addition, the agreement provides for the companies to add further  soft‐gelatin product candidates for development and commercialization, as new branded, soft‐ gelatin, capsule‐based drug products become available in the marketplace. 
  • "Glenmark is an ideal partner to expand our soft‐gelatin technology into much needed therapeutic categories and markets,” said Gonzalo Ballesteros, Managing Director of Cyndea.  “Cyndea has made significant financial investments in both its new Madrid‐based research and development facility and state‐of‐the‐art production facility located in Soria, Spain. Cyndea is a  global, market‐leading supplier of generic, prescription, soft‐gelatin capsules in the world and our  partnership with Glenmark provides expanded access into North America." 
If you want to more information regarding the Stock tips,commodity tipsnifty tips missed call @ 9069102223 or fill form http://24cfin.com/free-trial 

Comments

Popular posts from this blog

Equity Report Outlook|24 carat financial services | 21 june 2017

Morning Update of Indian Share Market- 5 December 2018

Place Of NRIs As Per The Taxation Norms